Antibodies

View as table Download

TNF-A Capture mouse monoclonal antibody, ELISA and Luminex validated, clone MAb1

Applications ELISA, LMNX
Reactivities Human
Conjugation Unconjugated
Matched ELISA Pair TA700026

Anti-Human TNF-a Goat Polyclonal Antibody

Applications ELISA, IHC
Reactivities Human
Conjugation Unconjugated

TNF alpha (TNF) mouse monoclonal antibody, clone B1E4, Aff - Purified

Applications ELISA, WB
Reactivities Human
Conjugation Unconjugated

Anti-Human TNF-a Rabbit Polyclonal Antibody

Applications ELISA, IHC
Reactivities Human
Conjugation Unconjugated

Biotinylated Anti-Human TNF-a Goat Polyclonal Antibody

Applications ELISA
Reactivities Human
Conjugation Unconjugated

Biotinylated Anti-Human TNF-a Rabbit Polyclonal Antibody

Applications ELISA
Reactivities Human
Conjugation Unconjugated

Biotinylated Anti-Murine TNF-a Goat Polyclonal Antibody

Applications ELISA
Reactivities Murine
Conjugation Unconjugated

Anti-Murine TNF-a Goat Polyclonal Antibody

Applications ELISA
Reactivities Murine
Conjugation Unconjugated

TNF alpha Rabbit polyclonal Antibody

Applications ELISA, IHC, WB
Reactivities Human, Mouse
Conjugation Unconjugated

TNF alpha Rabbit polyclonal Antibody

Applications ELISA, IF, IHC, WB
Reactivities Human, Mouse, Rat
Conjugation Unconjugated

Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))

Applications ELISA, FC
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))

Applications ELISA, FC
Reactivities Human
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))

Applications ELISA, FC
Reactivities Human
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))

Applications ELISA
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))

Applications ELISA
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))

Applications ELISA
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))

Applications ELISA, IF, IHC
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))

Applications ELISA, IF, IHC
Reactivities Human
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))

Applications ELISA, IF, IHC
Reactivities Human
Conjugation Unconjugated
Modifications NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.